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Abstract
Background: The LMA Protector™ is the latest CE marked single use supraglottic airway device. This airway device
provides access and functional separation of the respiratory and digestive tracts. There are two ports (male, female
ports) to provide suction in the laryngeal region and insertion of the gastric tube. The aim of our study is to assess
the ease of use, airway quality, device positioning, airway leak and complications associated with initial clinical
experience in LMA Protector™ usage.
Methods: This is an initial investigation of LMA Protector™ airway device. We conducted a preliminary assessment
in the anaesthetised women who underwent minor gynaecological procedures with spontaneous ventilation in
order to evaluate the performance of the airway device.
Results: Insertion was successful on first and second attempts in 23 (88.5%) and 3 (11.5%) respectively. Median
[IQR (range)] insertion time was 19 [17-21(14-58)] seconds. Airway leak pressure was 25.5 [23-29(21-30] cmH2O.
On fibreoptic examination via the device, vocal cords were visible in all 26 patients. There were no alternative
airway use or airway manipulations required during maintenance of anaesthesia. Six patients had sore throat
24 h after procedures and there was no dysphagia or hoarseness.
Conclusion: This pilot study of the LMA protector shows that the device is easily inserted with fast insertion time,
providing a reliable and adequate airway seal.
Trial registration: Clinicaltrials.gov Registration NCT02531256. Retrospectively registered on August 21, 2015.
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Background
Airway management is a crucial part of general anaes-
thesia. The LMA Protector™ is the latest innovation from
the inventors of laryngeal mask (Teleflex Medical, Co.
Westmeath, Ireland). It is a CE marked single use supra-
glottic airway device (SAD). It is made primarily of sili-
cone, latex free and allows insertion without the need for
digital or introducer tool guidance. Similar to the LMA
Supreme and LMA Proseal (p-LMA), the LMA Protector™
has an integral bite-block that reduces the potential for
tube damage and obstruction by biting. The device has a
fixation system which prevents proximal displacement
during use ensuring that the distal end seals around the
upper oesophageal sphincter.
The features of the LMA Protector™ include a func-
tional separation of the respiratory and digestive tracts.
The anatomically shaped airway tube is elliptical in cross
section and ends distally at the laryngeal mask. Different
from other SADs, the LMA Protector™ contains two drain
channels which emerge as separate ports proximally. The
drain channels continue distally and enters a chamber lo-
cated behind the cuff bowl. The chamber further narrows
distally into an orifice located at the end of the cuff to
communicate distally with the upper oesophageal sphinc-
ter. A suction tube may be attached to the male drainage
port around the laryngeal region or a well lubricated
gastric tube may be passed through the female drainage
port to the stomach (Fig. 1).
Although the physical characteristics of LMA-Protector
were reported, currently there are limited reports on
the role of LMA Protector™ in airway management [1].
We conducted this preliminary assessment in the
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anaesthetised women who underwent minor gynaeco-
logical procedures with spontaneous ventilation in order
to evaluate its performance as part of the initial investi-
gation of the airway device by the sponsor.
Methods
The Singhealth Centralised Institutional Review Board
(CIRB Reference: 2013/709/D) approval and clinical
trials registration (NCT02531256) was obtained for this
study and every subject gave written informed consent.
The study period was between October 2014 and January
2015. The inclusion criteria were female patients who
were American Society of Anesthesiologists (ASA) class 1
and 2, 21 to 70 years old and were expected to undergo
minor gynaecological procedure with general anaesthesia
and airway management using a SAD. Patients were
excluded if they had a body mass index of 30 kg/m2 or
more, known gastro-oesophageal reflux, increased risk
of aspiration, upper airway pathology and mouth open-
ing of less than 2 cm.
All anaesthetists participating in the study were ex-
perienced in the use of LMA Supreme and p-LMA.
Each investigator had performed more than 500 LMA
insertions. Before recruiting subjects in this study, each
anaesthetist was instructed in the use of the LMA Pro-
tector using an airway mannikin and used the device
to manage the airways of 14 patients. Data from these
patients are not included in this analysis.
The Samsoon and Young modification of the Mallampati
classification was used to assess the airways of all sub-
jects [2]. We applied standardised monitoring (gas ana-
lyser, pulse oximeter, intermittent non-invasive blood
pressure monitor, electrocardiogram) in all patients
prior to induction of anaesthesia. The LMA Protector
cuff was completely deflated and a water-based lubri-
cant was applied to the posterior part of cuff and airway
tube. The LMA protector size 3 was utilised for all sub-
jects. After pre-oxygenation, we induced anaesthesia
with fentanyl 1.5 to 2 mcg/kg, propofol 2 to 3 mg/kg
and maintained anaesthesia with sevoflurane with an
end tidal concentration of 2 to 3% in oxygen until the
jaw was considered relaxed at the discretion of the in-
vestigators during airway manipulation. No neuromus-
cular blockade was used.
All subjects were placed in a semi-sniffing position.
Under direct vision, the tip of the device was pressed
flat against the hard palate. Keeping the airway tube
close to the chin, the device was rotated inwards in one
smooth circular movement similar to insertion of the
LMA Supreme, until definite resistance was felt. Ease
of device insertion was recorded as ‘no or minimal re-
sistance’, ‘moderate resistance’, ‘severe resistance’ and
‘impossible to pass without excessive force’. We allowed
up to 3 attempts at LMA Protector insertion. The num-
ber of attempts at insertion and the time to achieve air-
way (time from pickup of the LMA Protector to the
presence of CO2 trace on capnography) were recorded.
The cuff was then inflated initially with 15mls of air
and further inflated to achieve an intra-cuff pressure of
60cmH2O using a separate pressure measurement de-
vice. The LMA Protector was secured to the patient’s
face by adhesive tape.
The anatomical airway position of the LMA Protector
was assessed by fiberoptic examination via the airway
channel. The view via the airway was scored as follows:
Grade 1, clear view of the vocal cords; Grade 2, view of
the arytenoids only; Grade 3, view of the epiglottis only;
Grade 4, no laryngeal structures visible [3]. Subse-
quently, fiberoptic examination was also done via the
gastric tube to assess the gastric channel patency. The
suprasternal notch test was performed by applying a
bolus of gel on the male drain port and occluding the
female drain port, whilst another investigator applied
suprasternal notch pressure.
Suction was then applied to the male port and the
presence of negative suction was assessed by feeling for
negative pressure at the female port. This is to assess for
seal between the gastric access channel, male and female
ports. A well lubricated 14 F gastric tube was then
passed through the female port into the gastric access
channel (Fig. 1). Successful insertion into the stomach
was confirmed by auscultation over the stomach during
injection of 10 ml air into the gastric tube. We adjusted
the cuff pressure to 60cmH2O and measured the oro-
pharyngeal leak pressure at this intra-cuff pressure with
a fresh gas flow of 4 L/min of oxygen. We closed the ex-
piratory valve of the circle anaesthetic breathing system
and noted the airway pressure in the breathing system at
which there was equilibration or up to a maximum pres-
sure of 40cmH2O.
Fig. 1 The LMA Protector™ contains two separate drain channels
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Failed insertion was defined by any of the following
criteria: (1) failed passage into the pharynx; (2) malposi-
tion (air leaks, negative tap test results, and failed gastric
tube insertion if pharyngeal placement was successful);
and (3) ineffective ventilation (maximum expired tidal
volume < 8 ml/kg or end-tidal carbon dioxide > 45 mmHg
if correctly positioned) [4]. During maintenance of anaes-
thesia, the number of airway manipulations during pro-
cedure (additional cuff inflation, position corrections) and
airway complications (intermittent obstruction, complete
obstruction, airway leak, need for alternate airway device)
were recorded. The subjects were maintained on spontan-
eous or assisted ventilation throughout the minor gynae-
cological procedures without neuromuscular blockade.
On emergence from anaesthesia, the LMA Protector was
removed by recovery staff when the patient was able to
open their mouth to command. During emergence and re-
moval, airway complications and the presence or absence of
blood or excessive secretions were recorded. On day 1 post-
operatively, subjects were interviewed on the presence or
absence of sore throat, dysphagia and hoarseness of voice.
Data were analysed by using SAS (Version 9.4, North
Carolina, USA). We used means and standard deviation
to describe continuous data; median, interquartile ranges
(IQR) and ranges for non-parametric data; and percent-
ages for categorical data.
Results
We studied 26 females undergoing minor gynaecological
procedures, the baseline and demographic characteristics
found in Table 1. All subjects were placed in the lithot-
omy position. The LMA protector size 3 was used in all
subjects as provided.
The airway and ventilation profiles for the subjects
are reported in Table 2. Overall, the LMA protector
was able to maintain good seal and adequate ventila-
tion in all the subjects. Insertion of the LMA protector
with subsequent ventilation was possible in all 26 sub-
jects. Successful insertion after the first attempt was
achieved in 23 subjects (88.5%) and after the second at-
tempt in 3 subjects (11.5%). There was ‘no or minimal
resistance’ to insertion in 25 subjects and ‘moderate
resistance’ in 1 subject. The median time to achieve
airway was 19.0 s (IQR 17.0 to 21 s, range 14.0 to
58.0 s). The median volume of air to achieve intra-cuff
pressure of 60 cmH2O was 15 ml (IQR 15 to 17 ml,
range 13 to 18 ml). The suprasternal notch test was
positive in all 26 subjects.
Fiberoptic inspection through the airway tube was
performed in all subjects and the vocal cords were vis-
ible in all 26 subjects. Negative pressure suction was
felt at the female port for all subjects when suction
was applied at the male port. Passage of a gastric tube
via the female port was attempted in all subjects. This
was successful at the first attempt in 24 subjects, at the
second attempt in 1 subject and was not possible in 1
subject. The suprasternal notch test was positive in all
subjects. The median oropharyngeal leak pressure was
25.5 cmH2O (IQR 23.0 to 29.0 cmH2O, range 21.0 to
30.0 cmH2O).






Age; years 26 43.3 (11.5)
Body Weight; kg 26 60.5 (9.4)
Body Mass Index; kg/m2 26 24.9 (3.4)
ASA Status:
Grade 1 16 61.5%






Duration of Procedures; min 26 19 [12-32]
The data are represented as mean (SD), median [range] or number
(% percentage)
Table 2 Airway and ventilation profile
Successful insertion LMA, n (%)
1st attempt; 23 (88.5%)
2nd attempt; 3 (11.5%)
Resistance on insertion of airway, n (%)
No or minimal; 25 (96.2)
Moderate; 1 (3.8)
Time to successful airway placement; sec 19 (17-21 [14-58])
Volume of air to achieve intra-cuff pressure
of 60 cm H2O; ml
15 (15-17 [13-18])
Vocal cord visibility under fibre-optic inspection, n (%);
Grade 1; 26(100%)
Grade 2; 0 (0%)
Grade 3; 0 (0%)
Successful gastric tube insertion, n (%)
1st attempt; 24 (92.4%)
2nd attempt; 1 (3.8%)
Not possible; 1 (3.8%)
Suprasternal notch test, n (%)
Positive; 26 (100%)
Negative; 0 (0%)
Oropharyngeal leak pressure; cm H2O 25.2 (23-29 [21-30])
The data are represented as number (% percentage) or median (IQR [range])
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The LMA Protector was used throughout the mainten-
ance of anaesthesia for all subjects. There was no airway
manipulation or airway complications observed. There
were no blood traces or excessive airway secretions ob-
served during emergence in the recovery room. The com-
plications and side effects profile is found in Table 3. At
1 day after surgery, 6 subjects (23.1%) reported sore throat
during the interview. There were no cases of dysphagia or
hoarseness of voice recorded.
Discussion
Our initial experience found a high first attempt and over-
all success rate of LMA Protector insertion and ventilation
in this case series of 26 subjects with normal airways. The
anatomical position of the airway was optimal in all sub-
jects and most subjects had successful gastric tube inser-
tion. There was no visible blood trace upon removal and
only a minority had sore throat after their procedures.
The LMA Protector was designed as a single use device
combining the features of earlier laryngeal mask airways
to enable ease of insertion, fixation and gastric access. The
additional features of the silicone material aim to make
the airway tube less rigid and softer, and to reduce muco-
sal trauma with potential to be used in longer duration
procedures. Furthermore, the gastric access allows for
larger flow of regurgitants at low pressure to prevent or
reduce gastric regurgitations.
The insertion of the LMA protector was easy in all the
cases in this pilot study. The first time insertion success
rate was 88.5% and the overall success rate was 100%. First
insertion success rate was higher for the LMA Supreme
than for the p-LMA during spontaneous respiration [3, 5].
Two previous studies of the LMA Supreme reported 92%
[6] and 100% [7] first time insertion success rate. Similar
to other studies, our study did not report any failures.
These features are similar to the LMA Classic (c-LMA),
p-LMA and I Gel [8–10].
The LMA protector provides adequate rapid securing of
the airway with a median time of 19 s. This is similar to
other SADs such as the LMA Supreme, p-LMA, c-LMA
and I Gel [10–15]. The LMA protector is a new airway de-
vice and the investigators involved had only performed 14
insertions before commencing on the study. With more
experience with the LMA protector, first time insertion
rates and insertion times could be improved.
The median oropharyngeal leak pressure was 25.5
cmH2O. This is similar to some SAD reports such as
LMA Supreme and I Gel [10, 12]. The LMA protector
also confers drainage of gastric contents compared to
the first generation c-LMA [11] However, higher oro-
pharyngeal leak pressures. Van Zundert et al. reported
that LMA Supreme oropharyngeal leak pressure was 37
cmH2O which was higher than ours [7]. The leak pres-
sure of the LMA Proseal was reported to be 32 cmH2O,
higher than that of the LMA protector [9, 11]. The
lower oropharyngeal leak pressure with the LMA pro-
tector should be investigated further, as this may have
implications to the maximum inspiratory ventilating
pressure and gastric aspiration risk. The gastric tube in-
sertion was successful on a majority of cases (25 out of
26). Most studied SADs also achieved high successful
insertion rate of the gastric tube [9, 10, 16].
The presence of double drainage channels, a unique
feature of the LMA protector, may reduce the risk of as-
piration and regurgitation. The p-LMA has been investi-
gated in a cadaveric study and found to offer significant
protection against aspiration [17]. Trivial regurgitation
was reported with the use of LMA Supreme, although
this was rare [10]. Our present study assessed the seal
between the gastric access channel, male and female
port to suggest ability for suctioning at the laryngeal re-
gion and was found to be present in all subjects. Further
studies on the LMA protector would need to be per-
formed in the setting of longer duration of surgery and
with the use of muscle relaxation.
The limitations of this study would include the small
number of subjects and the short duration of gynaeco-
logical procedures. This preliminary study is part of the
registration requirements for the sponsor of the LMA
protector. The effect of change to silicone material would
require longer surgical procedures to manifest, including a
reduction in airway complications such as sore throat and
hoarseness of voice. Furthermore, the presence of the
drainage channel opening was not fully evaluated due to
the short duration of procedure as airway secretions usu-
ally accumulate over longer periods of time. Only size 3
LMA Protector was utilised in this study, as only this size
was provided by the sponsor company. However, optimal
positioning of the airway device was obtained in all sub-
jects even if they were not in the recommended weight
range for the LMA size. Furthermore, the exact position
of the LMA with fibreoptic scope examination is still
limited, as malpositions may not be detected adequately
[18]. Further studies should be conducted with larger
number of subjects [19, 20].
Conclusion
Overall, the initial experience with the LMA protector
has found that this new SAD has a high first attempt
and overall insertion success rate. The anaesthetists
could rapidly achieve effective ventilation with reliable
Table 3 Side effects associated with the LMA protector
Blood or excessive airway secretion on airway device; % 0 (0%)
Sore throat after 1 day surgery; % 6 (23.1%)
Dysphagia or hoarseness of voice; % 0 (0%)
The data are represented as number (%)
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airway seal. Larger studies with larger number of subjects
are needed to investigate the effectiveness of the double
drainage channels in the setting of prolonged surgical pro-
cedures and with the use of muscle relaxation. The effect
of the softer silicone material on postoperative airway
complications should also be investigated.
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